Stronger Sell Today ACOR ranks #4344 as SELL CANDIDATE. Weaker Sell
Today ACOR ranks #4344 as SELL CANDIDATE.

ACOR stock Acorda Therapeutics

ACOR stock
Acorda Therapeutics

March 18, 2019
Change -1.64%
Chart period: 2018-12-19 - 2019-03-18
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Buy

PIVOT
Sell

MACD
Buy

Will ACOR stock price go up or down on Wed, 20 Mar 2019?

Acorda Therapeutics Forecast and Stock Analysis

Technical ACOR stock analysis for March 18, 2019.

Sell candidate since 2019-03-18
Shorts n/a
Cash n/a
Loans n/a
Beta 1.49
ROA 2.70

Acorda Therapeutics fell by -1.64% in the last day from $14.63 to $14.39 The price has risen in 6 of the last 10 days , but is still down by -1.64% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -749 700 shares and in total 661 333 shares bought and sold for approximately $9.52 million.

Close price at the end of the last trading day (Monday, 18th Mar 2019) of the ACOR stock was $14.39. This is 1.64% less than the trading day before Friday, 15th Mar 2019.

During day the stock fluctuated 4.62% from a day low at $14.30 to a day high of $14.96.

30 day high of the ACOR stock price was $15.41 and low was $12.55.
90 day high was $17.57 and low was $12.55.
52 week high for the Acorda Therapeutics - $36.35 and low - $12.55.

Trend

Acorda Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.94% during the next 3 months and, with 90% probability hold a price between $9.84 and $14.23 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Some negative signals were issued as well, and these may have some influence on the near short-term development. Acorda Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $14.72. On a fall, the stock will find some support from the short-term average at $14.16. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Friday March 15, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 55 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acorda Therapeutics finds support from accumulated volume at $14.30.

Support: $14.30 Price: $14.39 Resistance: $14.63

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.66 between high and low, or 4.62%. For the last week, the stock has had a daily average volatility of 3.68%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

Acorda Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Stronger Sell Today ACOR ranks #4344 as SELL CANDIDATE. Weaker Sell
Today ACOR ranks #4344 as SELL CANDIDATE.